LOWERING THE BINDING STRENGTH OF ANTI-CD19 CAR-T CELLS CAN REDUCE TOXICITY BUT AT THE COST OF IN VIVO ANTI-TUMOR EFFICACY (2022) Doetsch S, Warmuth L, D'Ippolito E, Honold B, Trebo M, Manlik W, Graml F, et al. Conference contribution DISSECTING THE INTERPLAY OF TCR AVIDITY OF NAIVE CD8+T CELLS AND TCR RECRUITMENT AFTER ANTIGEN EXPOSURE BY ENGINEERING POLYCLONAL REPERTOIRES (2022) Straub A, Grassmann S, Jarosch S, Muller T, Wagner K, Hammel M, Buchholz V, et al. Conference contribution GENE-TRANSFER METHODOLOGY AFFECTS CHIMERIC ANTIGEN RECEPTOR EXPRESSION AND REGULATION IN T-CELLS, AND DETERMINES ANTITUMOR POTENCY IN THE CONTEXT OF HIGH VS. LOW TARGET ANTIGEN DENSITY (2022) Gehrke L, Verbruggen C, Nerreter T, Schober K, Busch D, Einsele H, Sauer M, et al. Conference contribution A HIGH-THROUGHPUT WORKFLOW FOR THE FUNCTIONAL SCREENING AND CHARACTERIZATION OF CLINICALLY RELEVANT MHC CLASS I-RESTRICTED T CELL RECEPTORS FOR ADOPTIVE T CELL THERAPY (2022) D'Ippolito E, Scheu S, Wagner K, Kazeroonian A, Hochholzer A, Graml F, Hamed N, et al. Conference contribution ORTHOTOPIC T CELL RECEPTOR REPLACEMENT NEXT - GENERATION ENGINEERING OF T CELLS FOR THERAPY (2022) Schober K Conference contribution Adult and cord blood-derived high-affinity gB-CAR-T cells effectively react against human cytomegalovirus infections (2020) Olbrich H, Theobald SJ, Slabik C, Gerasch L, Schneider A, Mach M, Shum T, et al. Journal article Steerable Induction of the Thymosin β4/MRTF-A Pathway via AAV-Based Overexpression Induces Therapeutic Neovascularization (2018) Ziegler T, Kraus M, Husada W, Gesenhues F, Jiang Q, Pinkenburg O, Trenkwalder T, et al. Journal article Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the Race. (2018) Harrer DC, Dörrie J, Schaft N Journal article, Review article Gene Therapy for Modulation of T Cell Mediated Immune Response Provoked by Corneal Transplantation (2017) Pastak M, Kleff V, Saban DR, Czugala M, Steuhl KP, Erguen S, Singer BB, Fuchsluger T Journal article